11/15/2019  5:24:49 PM Chg. +0.36 Volume Bid11/15/2019 Ask11/15/2019 Market Capitalization Dividend Y. P/E Ratio
47.03USD +0.77% 91,055
Turnover: 4.28 mill.
45.00Bid Size: 200 47.05Ask Size: 100 12.47 bill.USD 0.00% -

Business description

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company's core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.
 

Management board & Supervisory board

CEO
Stephen P. MacMillan
Management board
Karleen Oberton, Allison Bebo, Erik Anderson, Jan Verstreken, Jay A. Stein, John M. Griffin, Kevin R. Thornal, Michael Watts, Monica Aguirre Berthelot, Patrick Brady, Peter J. Valenti III, Sanjay Prabhakaran, Sean S. Daugherty
Supervisory board
Stephen P. MacMillan, Amy M. Wendell, Charles J. Dockendorff, Christiana Stamoulis, Ludwig N. Hantson, Namal Nawana, Sally W. Crawford, Scott Garrett
 

Company data

Name: Hologic Inc.
Address: 250 Campus Drive,Marlborough, Massachusetts 01752, USA
Phone: +1-508-263-2900
Fax: -
E-mail: info@hologic.com
Internet: www.hologic.com/
Industry: Healthcare
Sector: Healthcare Providers
Sub sector: Healthcare Providers
End of financial year: 9/30
Free Float: 45.50%
IPO date: -

Investor relations

Name: Michael J. Watts
IR phone: +1-858-410-8588
IR Fax: -
IR e-mail: michael.watts@hologic.com

Main Shareholders

Freefloat
 
45.50%
T. Rowe Price Associates, Inc.
 
15.50%
Capital World Investors
 
9.60%
The Vanguard Group
 
9.60%
BlackRock, Inc.
 
7.20%
Wellington Management Group LLP
 
6.70%
Capital Research Global Investors
 
5.90%